Report Detail

Pharma & Healthcare Global Trastuzumab Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4744936
  • |
  • 28 September, 2026
  • |
  • Global
  • |
  • 124 Pages
  • |
  • GIR
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Trastuzumab Injection market size was valued at US$ 910 million in 2025 and is forecast to a readjusted size of US$ 1291 million by 2032 with a CAGR of 5.2% during review period.
Trastuzumab is a targeted cancer drug and is also known by other names such as Herceptin, Herzuma and Ontruzant. It is a treatment for early and advanced breast cancer, advanced stomach cancer and cancer of where the food pipe joins your stomach (gastro oesophageal junction). Trastuzumab injection products are used with other medications or after other medications have been used to treat a certain type of breast cancer that has spread to other parts of the body. Trastuzumab injection products are also used during and after treatment with other medications to decrease the chance that a certain type of breast cancer will return. Trastuzumab injection products are also used with other medications to treat certain types of stomach cancer that have spread to other parts of the body. Trastuzumab is in a class of medications called monoclonal antibodies. It works by stopping the growth of cancer cells.
This report is a detailed and comprehensive analysis for global Trastuzumab Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Trastuzumab Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Trastuzumab Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Trastuzumab Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Trastuzumab Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Trastuzumab Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Trastuzumab Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Roche, Celltrion, Amgen, Samsung Bioepsis, Mylan, Glenmark, AstraZeneca, Remegen Co., Ltd., Hisun Biopharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Trastuzumab Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
60 mg
150 mg
440 mg
Others
Market segment by Application
Hospitals
Clinics
Others
Major players covered
Pfizer
Roche
Celltrion
Amgen
Samsung Bioepsis
Mylan
Glenmark
AstraZeneca
Remegen Co., Ltd.
Hisun Biopharmaceutical
Shanghai Henlius Biotech
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Trastuzumab Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Trastuzumab Injection, with price, sales quantity, revenue, and global market share of Trastuzumab Injection from 2021 to 2026.
Chapter 3, the Trastuzumab Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Trastuzumab Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Trastuzumab Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Trastuzumab Injection.
Chapter 14 and 15, to describe Trastuzumab Injection sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Trastuzumab Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 60 mg
    • 1.3.3 150 mg
    • 1.3.4 440 mg
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Trastuzumab Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospitals
    • 1.4.3 Clinics
    • 1.4.4 Others
  • 1.5 Global Trastuzumab Injection Market Size & Forecast
    • 1.5.1 Global Trastuzumab Injection Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Trastuzumab Injection Sales Quantity (2021-2032)
    • 1.5.3 Global Trastuzumab Injection Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Trastuzumab Injection Product and Services
    • 2.1.4 Pfizer Trastuzumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Pfizer Recent Developments/Updates
  • 2.2 Roche
    • 2.2.1 Roche Details
    • 2.2.2 Roche Major Business
    • 2.2.3 Roche Trastuzumab Injection Product and Services
    • 2.2.4 Roche Trastuzumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Roche Recent Developments/Updates
  • 2.3 Celltrion
    • 2.3.1 Celltrion Details
    • 2.3.2 Celltrion Major Business
    • 2.3.3 Celltrion Trastuzumab Injection Product and Services
    • 2.3.4 Celltrion Trastuzumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Celltrion Recent Developments/Updates
  • 2.4 Amgen
    • 2.4.1 Amgen Details
    • 2.4.2 Amgen Major Business
    • 2.4.3 Amgen Trastuzumab Injection Product and Services
    • 2.4.4 Amgen Trastuzumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Amgen Recent Developments/Updates
  • 2.5 Samsung Bioepsis
    • 2.5.1 Samsung Bioepsis Details
    • 2.5.2 Samsung Bioepsis Major Business
    • 2.5.3 Samsung Bioepsis Trastuzumab Injection Product and Services
    • 2.5.4 Samsung Bioepsis Trastuzumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Samsung Bioepsis Recent Developments/Updates
  • 2.6 Mylan
    • 2.6.1 Mylan Details
    • 2.6.2 Mylan Major Business
    • 2.6.3 Mylan Trastuzumab Injection Product and Services
    • 2.6.4 Mylan Trastuzumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Mylan Recent Developments/Updates
  • 2.7 Glenmark
    • 2.7.1 Glenmark Details
    • 2.7.2 Glenmark Major Business
    • 2.7.3 Glenmark Trastuzumab Injection Product and Services
    • 2.7.4 Glenmark Trastuzumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Glenmark Recent Developments/Updates
  • 2.8 AstraZeneca
    • 2.8.1 AstraZeneca Details
    • 2.8.2 AstraZeneca Major Business
    • 2.8.3 AstraZeneca Trastuzumab Injection Product and Services
    • 2.8.4 AstraZeneca Trastuzumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 AstraZeneca Recent Developments/Updates
  • 2.9 Remegen Co., Ltd.
    • 2.9.1 Remegen Co., Ltd. Details
    • 2.9.2 Remegen Co., Ltd. Major Business
    • 2.9.3 Remegen Co., Ltd. Trastuzumab Injection Product and Services
    • 2.9.4 Remegen Co., Ltd. Trastuzumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Remegen Co., Ltd. Recent Developments/Updates
  • 2.10 Hisun Biopharmaceutical
    • 2.10.1 Hisun Biopharmaceutical Details
    • 2.10.2 Hisun Biopharmaceutical Major Business
    • 2.10.3 Hisun Biopharmaceutical Trastuzumab Injection Product and Services
    • 2.10.4 Hisun Biopharmaceutical Trastuzumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Hisun Biopharmaceutical Recent Developments/Updates
  • 2.11 Shanghai Henlius Biotech
    • 2.11.1 Shanghai Henlius Biotech Details
    • 2.11.2 Shanghai Henlius Biotech Major Business
    • 2.11.3 Shanghai Henlius Biotech Trastuzumab Injection Product and Services
    • 2.11.4 Shanghai Henlius Biotech Trastuzumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Shanghai Henlius Biotech Recent Developments/Updates

3 Competitive Environment: Trastuzumab Injection by Manufacturer

  • 3.1 Global Trastuzumab Injection Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Trastuzumab Injection Revenue by Manufacturer (2021-2026)
  • 3.3 Global Trastuzumab Injection Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Trastuzumab Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Trastuzumab Injection Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Trastuzumab Injection Manufacturer Market Share in 2025
  • 3.5 Trastuzumab Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Trastuzumab Injection Market: Region Footprint
    • 3.5.2 Trastuzumab Injection Market: Company Product Type Footprint
    • 3.5.3 Trastuzumab Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Trastuzumab Injection Market Size by Region
    • 4.1.1 Global Trastuzumab Injection Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Trastuzumab Injection Consumption Value by Region (2021-2032)
    • 4.1.3 Global Trastuzumab Injection Average Price by Region (2021-2032)
  • 4.2 North America Trastuzumab Injection Consumption Value (2021-2032)
  • 4.3 Europe Trastuzumab Injection Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Trastuzumab Injection Consumption Value (2021-2032)
  • 4.5 South America Trastuzumab Injection Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Trastuzumab Injection Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Trastuzumab Injection Sales Quantity by Type (2021-2032)
  • 5.2 Global Trastuzumab Injection Consumption Value by Type (2021-2032)
  • 5.3 Global Trastuzumab Injection Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Trastuzumab Injection Sales Quantity by Application (2021-2032)
  • 6.2 Global Trastuzumab Injection Consumption Value by Application (2021-2032)
  • 6.3 Global Trastuzumab Injection Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Trastuzumab Injection Sales Quantity by Type (2021-2032)
  • 7.2 North America Trastuzumab Injection Sales Quantity by Application (2021-2032)
  • 7.3 North America Trastuzumab Injection Market Size by Country
    • 7.3.1 North America Trastuzumab Injection Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Trastuzumab Injection Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Trastuzumab Injection Sales Quantity by Type (2021-2032)
  • 8.2 Europe Trastuzumab Injection Sales Quantity by Application (2021-2032)
  • 8.3 Europe Trastuzumab Injection Market Size by Country
    • 8.3.1 Europe Trastuzumab Injection Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Trastuzumab Injection Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Trastuzumab Injection Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Trastuzumab Injection Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Trastuzumab Injection Market Size by Region
    • 9.3.1 Asia-Pacific Trastuzumab Injection Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Trastuzumab Injection Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Trastuzumab Injection Sales Quantity by Type (2021-2032)
  • 10.2 South America Trastuzumab Injection Sales Quantity by Application (2021-2032)
  • 10.3 South America Trastuzumab Injection Market Size by Country
    • 10.3.1 South America Trastuzumab Injection Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Trastuzumab Injection Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Trastuzumab Injection Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Trastuzumab Injection Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Trastuzumab Injection Market Size by Country
    • 11.3.1 Middle East & Africa Trastuzumab Injection Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Trastuzumab Injection Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Trastuzumab Injection Market Drivers
  • 12.2 Trastuzumab Injection Market Restraints
  • 12.3 Trastuzumab Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Trastuzumab Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Trastuzumab Injection
  • 13.3 Trastuzumab Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Trastuzumab Injection Typical Distributors
  • 14.3 Trastuzumab Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Trastuzumab Injection. Industry analysis & Market Report on Trastuzumab Injection is a syndicated market report, published as Global Trastuzumab Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Trastuzumab Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report